Brought to you by www.DealSearchOnline.com Week ending March 27, 2015: Recent Health Care M&A Deals Acquirer Target Price Pharmaceuticals Tabuk Pharmaceutical License to 3 erectile dysfunction drugs $85.6 million Nanolek Russian rights to Green Cross’...
Brought to you by www.DealSearchOnline.com Week ending March 20, 2015: Recent Health Care M&A Deals Acquirer Target Price Pharmaceuticals Ignyta, Inc. 4 oncology development programs $13.3 million Eli Lilly and Company License to HM71224 $50 million Daiichi Sankyo...
Brought to you by www.DealSearchOnline.com Week ending March 13, 2015: Recent Health Care M&A Deals Acquirer Target Price Pharmaceuticals Pernix Therapeutics Holdings, Inc. Zohydro® ER franchise $100 million Epizyme, Inc. Rights to EZH2 inhibitor $40 million Kura...
Brought to you by www.DealSearchOnline.com Week ending March 6, 2015: Recent Health Care M&A Deals Acquirer Target Price Behavioral Health Care Acadia Healthcare Company Quality Addiction Management $53 million Epic Health Services Clarity Service Group N/A...
Brought to you by www.DealSearchOnline.com Week ending February 27, 2015: Recent Health Care M&A Deals Acquirer Target Price Biotechnology Bristol-Myers Squibb Flexus Biosciences, Inc. $800 million Bristol-Myers Squibb Collaboration with Rigel Pharmaceuticals $30...
Brought to you by www.DealSearchOnline.com Week ending February 20, 2015: Recent Health Care M&A Deals Acquirer Target Price Biotechnology Sanofi SA License to small-molecule therapies N/A Intrexon Corporation ActoGeniX $60 million Cerecor Rights to KOR antagonist...